Bristol-Myers Squibb

PA 2021 Independent Pharmacies

DOJ False Claims Act Healthcare Fraud

Penalty

$41 million

Outcome

Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed Through Medicaid

Details

Bristol-Myers Squibb — DOJ Enforcement (2021)

DOJ took enforcement action against Bristol-Myers Squibb in PA in 2021 involving false claims act, healthcare fraud violations in the Independent Pharmacies sector.

Penalty: $41 million

Violation types: False Claims Act, Healthcare Fraud
Entity type: Pharmacy
Penalty type: Settlement
Location: PA

Source: DOJ Press Release — Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed Through Medicaid

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible's healthcare compliance layer enforces proper documentation, eligibility verification, and claims accuracy.

Source: DOJ Press Release — Bristol-Myers Squibb to Pay $75 Million to Resolve False Claims Act Allegations of Underpayment of Drug Rebates Owed Through Medicaid

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works